Distinct subsets of CD4 + CD25 + human regulatory T cells (T reg cells) are involved in the maintenance of immunological self-tolerance and the control of autoimmunity 1 . T reg cells are classified into two main subgroups according to their developmental origin, and both express the transcription factor Foxp3 (refs. 2, 3) . One subgroup arises from the thymus as a distinct lineage, and the other subgroup derives from the peripheral conversion of CD4 + CD25 − conventional T cells (T conv cells) 4, 5 . Experimental evidence indicates that T reg cell differentiation relies on multiple signaling pathways, such as those derived from the cytokine milieu, engagement of the T cell antigen receptor (TCR), the costimulatory molecule CD28, and signaling via interleukin 2 (IL-2) and its receptor (IL-2R). For example, the cytokine TGF-β can induce Foxp3 expression in T conv cells stimulated via the TCR, which leads to their conversion into inducible T reg cells (iT reg cells) with strong in vitro suppressive capacity 6, 7 . Additionally, chronic activation of CD4 + T cells in the presence of TGF-β can induce the differentiation of a T reg cell subset that suppresses antigen-specific T cell responses in both mice and humans 6, 7 . However, cytokines can be dispensable in the generation of human iT reg cells, as these cells can also be generated by in vitro stimulation of T conv cells in a cytokine-independent manner 8, 9 . In this context, homeostatic proliferation of T conv cells in vivo can produce a population of CD25 + T cells with low proliferative capacity and the ability to suppress antigen-specific T cell responses 10 . In vitro and in vivo studies have shown that the extent of signaling via the TCR and associated costimulatory molecules can affect the outcome of T cell differentiation 11, 12 . In this context, culture of CD4 + T cells in the presence of dendritic cells presenting low concentrations of antigen results in T reg cell proliferation together with the conversion of T conv cells into iT reg cells 13 . Therefore, the density and affinity of TCR ligation seem to control the induction of Foxp3, since maximal TCR stimulation seems to be detrimental to the differentiation of T reg cells, whereas optimal induction of Foxp3 is associated with suboptimal TCR engagement 14, 15 . Accordingly, antigen-specific T reg cells can be induced efficiently in mice when an agonist peptide is administrated in sub-immunogenic doses, as supra-physiological stimulation leads to the proliferation of CD4 + CD25 + T cells without Foxp3 expression 16 .
Distinct subsets of CD4 + CD25 + human regulatory T cells (T reg cells) are involved in the maintenance of immunological self-tolerance and the control of autoimmunity 1 . T reg cells are classified into two main subgroups according to their developmental origin, and both express the transcription factor Foxp3 (refs. 2,3) . One subgroup arises from the thymus as a distinct lineage, and the other subgroup derives from the peripheral conversion of CD4 + CD25 − conventional T cells (T conv cells) 4, 5 . Experimental evidence indicates that T reg cell differentiation relies on multiple signaling pathways, such as those derived from the cytokine milieu, engagement of the T cell antigen receptor (TCR), the costimulatory molecule CD28, and signaling via interleukin 2 (IL-2) and its receptor (IL-2R). For example, the cytokine TGF-β can induce Foxp3 expression in T conv cells stimulated via the TCR, which leads to their conversion into inducible T reg cells (iT reg cells) with strong in vitro suppressive capacity 6, 7 . Additionally, chronic activation of CD4 + T cells in the presence of TGF-β can induce the differentiation of a T reg cell subset that suppresses antigen-specific T cell responses in both mice and humans 6, 7 . However, cytokines can be dispensable in the generation of human iT reg cells, as these cells can also be generated by in vitro stimulation of T conv cells in a cytokine-independent manner 8, 9 . In this context, homeostatic proliferation of T conv cells in vivo can produce a population of CD25 + T cells with low proliferative capacity and the ability to suppress antigen-specific T cell responses 10 . In vitro and in vivo studies have shown that the extent of signaling via the TCR and associated costimulatory molecules can affect the outcome of T cell differentiation 11, 12 . In this context, culture of CD4 + T cells in the presence of dendritic cells presenting low concentrations of antigen results in T reg cell proliferation together with the conversion of T conv cells into iT reg cells 13 . Therefore, the density and affinity of TCR ligation seem to control the induction of Foxp3, since maximal TCR stimulation seems to be detrimental to the differentiation of T reg cells, whereas optimal induction of Foxp3 is associated with suboptimal TCR engagement 14, 15 . Accordingly, antigen-specific T reg cells can be induced efficiently in mice when an agonist peptide is administrated in sub-immunogenic doses, as supra-physiological stimulation leads to the proliferation of CD4 + CD25 + T cells without Foxp3 expression 16 .
Distinct metabolic pathways control the function and differentiation of T cells [17] [18] [19] . The activation of CD4 + T cells requires metabolic reprogramming characterized by diminished lipid oxidation and increased glycolysis [17] [18] [19] . Metabolic enzymes can influence T cell fate by modulating both lineage-specific differentiation and cytokine production 20, 21 . Here we found that highly suppressive human iT reg cells were generated in the absence of exogenous regulatory-type cytokines (i.e., TGF-β or IL-10) following suboptimal stimulation of T conv cells via the TCR. They represented the highly glycolytic and metabolically active fraction of proliferating T conv cells and depended for their induction on the expression of Foxp3 splicing variants containing exon 2 (Foxp3-E2). Among all splicing variants of human Foxp3, the variant produced from Foxp3-E2 (called 'Foxp3-E2' here) has been shown to serve a major role in conferring suppressive ability onto T reg cells [22] [23] [24] . Therefore, we focused on the metabolic determinants that led to the induction of Foxp3-E2 in human iT reg cells and found that glycolysis controlled the generation of iT reg cells through localization of the glycolytic enzyme enolase-1 to the nucleus. Enolase-1 directly affected the expression of Foxp3-E2 after binding to Foxp3 regulatory regions, such as the promoter and conserved noncoding sequence 2 (CNS2). We confirmed our findings in studies of subjects with the autoimmune diseases relapsing-remitting multiple sclerosis (RRMS) or type 1 diabetes (T1D), in whom we observed impaired glycolysis and Foxp3-E2 expression in iT reg cells.
RESULTS

Generation of iT reg cells after suboptimal TCR stimulation
To determine whether the induction of human iT reg cells from T conv cells could be achieved through weak stimulation of the TCR in the absence of exogenous cytokines, we obtained peripheral blood mononuclear cells (PBMCs) from healthy human subjects, negatively selected T conv cells (purity, >98%) from those cells and activated them (via the TCR) for 36 h in vitro with beads coated with monoclonal antibody (mAb) to the invariant signaling protein CD3 plus mAb to CD28 (at a density of 0.1 bead per cell) (Supplementary Fig. 1 ). At 24 h after activation, we assessed cellular metabolism (glycolysis, mitochondrial respiration and fatty acid oxidation (FAO)) by measuring the extracellular acidification rate (ECAR) and oxygen-consumption rate (OCR). T conv cells underwent an increase in their mitochondrial respiration rate (OCR) and used both glucose and fatty acids, as indicated by an increase in glycolysis and FAO (Fig. 1a,b) . At 36 h after activation, we sorted T conv cells by flow cytometry into three subsets on the basis of their cell-surface expression of the T cell-activation marker CD25. We subsequently assessed the proliferation marker Ki67, phosphorylation of S6 (a downstream target of the metabolic checkpoint kinase mTOR) 59.7 (21, 900) 71.6 (9,365) 86.9 (11, 700) 
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and Foxp3 in cells with high CD25 expression (CD25 hi ), intermediate CD25 expression (CD25 int ) or low CD25 expression (CD25 lo ) and found that CD25 hi cells had highest levels of all these (Fig. 1c) . In parallel, we evaluated the ability to suppress in vitro the proliferation of CD4 + T cells labeled with the division-tracking dye CFSE and stimulated with mAb to CD3 plus mAb to CD28. We found that the subset with the highest expression of CD25, Ki67 and Foxp3 and greatest phosphorylation of S6 also had the strongest suppressive activity (Fig. 1d) and that the suppression was contact dependent ( Supplementary  Fig. 2a) . We also evaluated the methylation status of Foxp3 CNS2 to assess the stability of Foxp3 expression (a more highly methylated CNS2 is related to diminished stability). The frequency of CNS2 methylation in iT reg cells was low and similar to that observed in freshly isolated T reg cells (Supplementary Fig. 2b) . The low CNS2-methylation status, high suppressive activity and expression of T reg cell-characteristic surface markers (CTLA-4, PD-1, GITR and CD71) were retained for up to 10 d of culture in the presence of IL-2, at levels similar to those of the initially generated iT reg cells (at 36 h) ( Supplementary Fig. 2b-d) .
The generation of iT reg cells did not depend on TGF-β and IL-10, since neutralization of these cytokines in vitro did not alter the induction of iT reg cells (data not shown). These results indicated that human iT reg cells could be induced from T conv cells stimulated by weak engagement of TCR in the absence of exogenous cytokines and that they retained their suppressive capacity overtime.
Glycolysis and FAO in the generation and function of iT reg cells
Since the generation and function of T cells depend on underlying metabolic programs [17] [18] [19] , we evaluated the metabolic pathways involved in the generation of iT reg cells. We activated T conv cells in the presence or absence of a specific inhibitor of glycolysis (2-deoxy-d-glucose (2DG)) and a specific inhibitor of FAO (etomoxir (Etx)) (Supplementary Fig. 3 ). 2DG-treated T conv cells had lower glycolysis than that of untreated T conv cells and had mitochondrial respiration (Fig. 2a) and FAO (Fig. 2b ) similar to that of untreated T conv cells. In contrast, treatment with Etx affected the FAO rate (Fig. 2b) and decreased the mitochondrial respiration without any substantial effect on glycolysis (Fig. 2a) .
Although both compounds inhibited the upregulation of CD25 expression, Foxp3 expression was much lower in CD25 hi T cells generated in the presence of 2DG and sorted by flow cytometry (iT reg -2DG cells) and was higher in sorted CD25 hi T cells generated in the presence of Etx (iT reg -Etx cells) than in untreated (control (CTR)) CD25 hi T cells (iT reg -CTR cells) (Fig. 2c) . To determine whether the metabolic perturbations were associated with an altered regulatory function, we assessed the ability of iT reg -2DG cells and iT reg -Etx cells to suppress Fig. 1a ; above plots), grown in the absence (control (CTR)) or in the presence of 2DG or Etx (key) (as in Supplementary  Fig. 3 ). (b) OCR, quantifying FAO, of T conv cells stimulated for 24 h in vitro with mAb to CD3 plus mAb to CD28 (in conditions as in a, right; above plots), grown in the absence of 2DG or Etx (control (CTR)) or in the presence of 2DG (left) or Etx (middle), and in the presence of palmitate alone or palmitate plus inhibitor (as in Fig. 1b) , and the FAO index of those cells (right; calculated as in Fig. 1b) . npg the proliferation of CD4 + T cells in vitro. iT reg -2DG cells displayed less suppressive function than that of iT reg -CTR cells, whereas iT reg -Etx cells had higher suppressive activity than that of iT reg -CTR cells (Fig. 2d) . Together these results indicated that glycolysis was necessary for the generation and suppressive function of human iT reg cells.
Biochemical signature of iT reg cells
To better understand the molecular basis of the findings reported above for iT reg cells, we studied cell metabolism, cytokine-related signaling and Foxp3 expression during specific metabolic perturbations. Immunoblot analysis of iT reg cells stimulated in vitro for 1 h with mAb to CD3 plus mAb to CD28 showed that both 2DG and Etx reduced the activation of mTOR in iT reg cells, in terms of the phosphorylation of S6, but via different mechanisms (Fig. 3) . Indeed, while 2DG abolished the phosphorylation of S6, Etx increased the total amount of S6 without increasing its activity in terms of phosphorylation. Moreover, iT reg -2DG cells had lower expression of enolase-1 than that of iT reg -CTR cells, whereas iT reg -Etx cells had enolase-1 expression similar to that of iT reg -CTR cells. Also, iT reg -2DG cells had less phosphorylation of the signal transducer STAT3 than that of iT reg -CTR cells, whereas iT reg -Etx cells had an amount of STAT3 phosphorylation similar to that of iT reg -CTR cells. The IL-2-IL-2R-STAT5 signaling pathway has a central role in the induction of Foxp3 and in the generation and homeostasis of T reg cells 25, 26 . We found profound impairment in the activation of STAT5 in iT reg -2DG cells following TCR stimulation, whereas the induction of STAT5 phosphorylation was greater in stimulated iT reg -Etx cells than in their iT reg -CTR counterparts.
Human Foxp3 has various splicing variants; however, despite the importance of Foxp3 in T reg cells, the regulation and functional activity of Foxp3 isoforms remain poorly understood [22] [23] [24] . Since we observed that glycolysis was necessary for the induction of human iT reg cells, we evaluated the differential effects of metabolic perturbations on Foxp3 isoforms. Specifically, we found that 2DG hampered induction of the 47-, 44-and 38-kilodalton (kDa) forms of Foxp3 but favored expression of the 49-kDa form (Fig. 3) . In contrast, Etx increased the expression of the 47-kDa form but did not affect the expression of the 49-, 44-or 38-kDa forms (Fig. 3) . Of note, the densitometric sum of total Foxp3 forms showed no difference among the three iT reg cell populations (Fig. 3) , which suggested differential metabolic regulation of the various splicing forms of Foxp3 in iT reg cells. We confirmed these data at the mRNA level by RT-PCR analysis (data not shown). Overall, these analyses revealed that glycolysis controlled the generation of human iT reg cells via a specific biochemical machinery involving the mTOR pathway, IL-2R signaling and the modulation of various splicing variants of Foxp3.
Metabolic programs and phenotypical characteristics of iT reg cells
Next we evaluated the phenotype and the metabolic profile of iT reg cells generated in the presence of inhibitors of either glycolysis or FAO. Inhibition of glycolysis with 2DG diminished expression of the iT reg -CTR iT reg -2DG iT reg -Etx
(fold) A r t i c l e s T reg cell markers CTLA-4, PD-1, GITR, CD39 and CD71, as well as the phosphorylation of S6, whereas Etx had an effect similar to that of 2DG on the expression of PD-1 and CD39 and phosphorylation of S6, but slightly reduced the expression of CD71 and CCR7, preserved the expression of CTLA-4, and upregulated the expression of GITR, compared with results obtained with no treatment (in iT reg -CTR cells) (Fig. 4a) . The measurement of ECAR (glycolysis) and OCR (FAO and oxidative phosphorylation) in iT reg cells indicated that iT reg -2DG cells had impaired glycolysis and mitochondrial respiration relative to that of iT reg -CTR cells (Fig. 4b) , with FAO rates similar to those of iT reg -CTR cells (Fig. 4c) . Etx affected FAO (Fig. 4c) and mitochondrial respiration (Fig. 4b ) but preserved glycolysis (Fig. 4b) , relative to results obtained with no treatment (in iT reg -CTR cells). These effects, secondary to the metabolic perturbations, were not associated with altered survival and/or viability of T cells, as indicated by staining with propidium iodide and annexin V, which was similar in iT reg -2DG, iT reg -Etx and iT reg -CTR cells (data not shown). Thus, inhibition of glycolysis impaired the generation and function of iT reg cells and reduced the induction of Foxp3 and the expression of T reg cell markers.
Glycolysis controls iT reg cells' suppressive function via Foxp3-E2
To better understand the effects of metabolism on the expression of the splicing variants of Foxp3, as they were related to the regulatory function of iT reg cells, we analyzed, at level of both mRNA and protein, the expression of all Foxp3 transcripts and that of the two main Foxp3 spliced forms [22] [23] [24] 26 : one containing exon 2 (Foxp3-E2), and the other lacking it (Fig. 5a) . Quantitative RT-PCR with primers spanning exons 9-11 (to amplify all transcripts) showed a 37-fold greater abundance of total Foxp3 mRNA in iT reg -CTR cells than in T conv cells (Fig. 5b) . iT reg -2DG cells had 50% less total Fig. 1a, right) , in the presence of palmitate alone or palmitate plus inhibitor (as in Fig. 1b) , and FAO index (right; calculated as in Fig. 1b ). *P < 0.0001 and **P < 0.005 (paired two-tailed Student's t-test). Data are from one experiment representative of five experiments (a), one experiment representative of two experiments with technical duplicates (b; mean ± s.e.m.) or three independent experiments with technical duplicates (c; mean ± s.e.m. n = 18 replicates).
Foxp3 mRNA, whereas iT reg -Etx cells had very slightly but significantly greater levels of total Foxp3 mRNA, than iT reg -CTR cells had (Fig. 5b) . Quantitative RT-PCR with specific primers for the amplification of transcripts containing Foxp3 exon 2 ( Fig. 5a) showed that the expression of Foxp3-E2 mRNA was twofold lower in iT reg -2DG cells and 1.4-fold higher in iT reg -Etx cells than in iT reg -CTR cells (Fig. 5b) .
To further assess whether 2DG and Etx regulated the splicing of exon 2 differentially, we did semiquantitative RT-PCR with primers spanning exons 1-3. 2DG affected only the expression of Foxp3-E2, whereas Etx increased the abundance of both Foxp3-E2 and Foxp3 lacking exon 2 compared with results obtained for untreated (iT reg -CTR) cells (Fig. 5b) . Next we sought to determine whether level of mRNA from the Foxp3 splicing forms correlated with protein expression in iT reg cells generated in the presence of metabolic inhibitors.
For this, we measured all splicing forms of Foxp3 protein by using two specific mAbs: one (PCH101) that recognizes all splicing variants of Foxp3 (through a common epitope of the amino terminus of Foxp3); the other (150D/E4) specific for the variants encoded by Foxp3-E2 (recognized through an epitope encoded by sequence present only in exon 2). Immunoblot analysis with mAb PCH101 revealed that the amount of the 49-kDa form of Foxp3 increased after treatment with each metabolic inhibitor, relative to its abundance in untreated (iT reg -CTR) cells, with this phenomenon being more evident in iT reg -2DG cells (Fig. 5c) . iT reg -2DG cells had substantially less of both the 47-kDa splicing form and 44-kDa splicing form than iT reg -CTR cells had, whereas the level of these forms was not altered in iT reg -Etx cells relative to that in iT reg -CTR cells (Fig. 5c) . The densitometric sum of the various Foxp3 splicing forms showed no difference among the three iT reg cell populations (Fig. 5c) , which 
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indicated that the effects induced by the metabolic inhibitors were specific for defined splicing variants of Foxp3.
To determine whether the lower abundance of the 44-to 47-kDa splicing forms had to be ascribed to a lower abundance of Foxp3-E2 (as observed by quantitative RT-PCR), we performed immunoblot analysis of the same cell lysates with mAb 150D/E4 to the variants encoded by Foxp3-E2 (Foxp3-E2), which detects a 47-kDa product. iT reg -2DG cells had much less Foxp3-E2, whereas iT reg -Etx cells had more Foxp3-E2, than iT reg -CTR cells had (Fig. 5c) . Flow cytometry confirmed that treatment with 2DG led to the generation of iT reg cells with reduced expression of Foxp3, both as total Foxp3 and Foxp3-E2, whereas Etx increased both total Foxp3 and Foxp3-E2 in iT reg cells, relative to their expression in untreated (iT reg -CTR) cells (Supplementary Fig. 4a) , and that these effects were dose dependent ( Supplementary Fig. 4b,c) . Thus, glycolysis and FAO controlled the expression of splicing variants of Foxp3 in iT reg cells differentially, at the level of both mRNA and protein.
Since iT reg -2DG cells displayed impaired suppressive capacity associated with reduced expression of Foxp3-E2, with the region of Foxp3 encoded by exon 2 being part of the Foxp3 transcriptional repressor domain [22] [23] [24] , we studied whether Foxp3-E2 was indispensable for the regulatory function of iT reg cells by using small interfering mRNA (siRNA) specific for the Foxp3-E2 domain (siRNA-E2). We generated iT reg cells in the presence of siRNA-E2 and assessed their ability to suppress the proliferation of CD4 + T cells in vitro. After confirming, by immunoblot analysis, siRNA-induced silencing in T conv cells stimulated with mAb to CD3 plus mAb to CD28 (Supplementary Fig. 5a ), we found that iT reg cells generated in the presence of siRNA-E2 had less suppressive ability than iT reg cells generated in the presence of control siRNA with a scrambled sequence (siRNA-Scr) (Fig. 5d) , despite the finding that iT reg cells generated in the presence of siRNA-E2 expressed the other Foxp3 splice variants (44 kDa) (Supplementary Fig. 5a ). Of note, iT reg cells generated in the presence of siRNA-E2 had an impaired suppressive phenotype (Fig. 5d ) similar to that of iT reg -2DG cells (Fig. 2d) . As an additional control, we also silenced Foxp3 exon 5, a common sequence for all Foxp3 transcripts, with siRNA (siRNA-E5); this reduced the abundance of all the Foxp3 splicing variants (Supplementary Fig. 5a ) and markedly hampered the generation of iT reg cells, as indicated by the substantial reduction in CD25 expression (data not shown). iT reg cells generated in the presence of siRNA-E5, sorted on the basis of their CD25 hi phenotype, had a suppressive ability similar to that of iT reg cells generated in the presence of siRNA-Scr (Fig. 5d) . These phenomena occurred because silencing of Foxp3 exon 5 reduced the induction of all Foxp3 splicing variants and, consequently, hampered the upregulation of CD25 expression and the generation of iT reg cells (data not shown). Since the sorting gate was on CD25 hi cells, it was likely that CD25 hi cells recovered from the silencing of Foxp3 exon 5 were those in which the knockdown had failed, which had retained their suppressive ability (Fig. 5d) . Overall, these analyses revealed that glycolysis controlled the expression of Foxp3-E2, which was necessary for the suppressive function of human iT reg cells.
Enolase-1 controls Foxp3-E2 expression
Several isoforms of enolase-1, a key glycolytic enzyme, can bind DNA [27] [28] [29] . Among them, the 37-kDa isoform (MBP-1) has been shown to regulate gene expression in various experimental systems [27] [28] [29] . Both the glycolytic enzyme enolase-1 and the transcriptional repressor MBP-1 arise from the gene ENo1 through the use of alternative translation start sites present on ENo1 mRNA 29, 30 . Published evidence suggests that enolase-1 isoforms have multifunctional roles, ranging from glycolytic activity in the cytoplasm to gene regulation in the nucleus 29, 30 . For this reason, we evaluated whether enolase-1 isoforms localized in the nuclear fraction of iT reg -CTR, iT reg -2DG and iT reg -Etx cells to control Foxp3 expression. Immunoblot analysis revealed that three different products of the alternative translation start sites of the ENo1 transcript (48, 37 and 31 kDa in size) were selectively greater in abundance in iT reg -2DG cells than in iT reg -CTR cells, whereas their amounts were similar in iT reg -Etx cells and iT reg -CTR cells (Fig. 6a) . To determine whether enolase-1 was involved in the regulation of Foxp3 in iT reg cells, we first evaluated the binding of enolase-1 to the Foxp3 regulatory elements and then assessed the effect of the silencing of ENo1 on Foxp3 mRNA expression. Chromatin-immunoprecipitation analysis revealed that the recruitment of enolase-1 to both the Foxp3 promoter and its CNS2 regions was greater in iT reg -2DG cells than in iT reg -CTR cells (Fig. 6b) ; in contrast, the association of enolase-1 with the Foxp3 promoter was much lower in iT reg -Etx cells than in iT reg -CTR cells, but its association with Foxp3 CNS2 was similar in iT reg -Etx cells and iT reg -CTR cells (Fig. 6b) . Freshly isolated, unstimulated T conv cells, which did not express Foxp3, had less cytoplasmic enolase-1 than did iT reg -CTR cells, and the recruitment of enolase-1 to the Foxp3 regulatory elements in these cells was similar to that in iT reg -2DG cells ( Supplementary Fig. 5b and Fig. 6b ).
To address whether enolase-1 directly controlled the splicing of Foxp3 mRNA, we silenced ENo1 by using ENO1-specific siRNA (siRNA-ENO1) during the generation of iT reg cells. After confirmation by quantitative RT-PCR that silencing of ENo1 occurred (Supplementary Fig. 5c ), we found that silencing of ENo1 restored expression of Foxp3 mRNA in iT reg -2DG cells (Fig. 6c) . Specifically, silencing of ENo1 in iT reg -2DG cells led to the recovery of all Foxp3 transcripts (fourfold greater abundance than in iT reg -2DG cells generated with siRNA-Scr) and an even greater recovery of Foxp3-E2 mRNA (13-fold greater abundance than in iT reg -2DG cells generated with siRNA-Scr) (Fig. 6c ). In addition, the level of Foxp3-E2 mRNA was significantly higher, whereas the level of total Foxp3 mRNA was slightly lower, in iT reg -CTR cells generated in the presence of siRNA-ENO1 than in those generated with siRNA-Scr (Fig. 6c) . Together these data established that enolase-1 specifically repressed the expression of Foxp3-E2 in iT reg cells.
Properties of CD4 + Foxp3-E2 + T cells
To investigate the physiological relevance of our findings reported above, we examined ex vivo CD4 + Foxp3-E2 + cells and their biological properties. CD4 + Foxp3-E2 + cells constituted (on average) 5.94% ± 2.68% (a) ECAR of T conv cells isolated from subjects with RRMS who had not undergone treatment (n = 6) and healthy subjects (CTR) (n = 14), then stimulated for 24 h in vitro with mAb to CD3 plus mAb to CD28 (in conditions as in Fig. 1a, left) . (d,e) ). Data are from six (RRMS) or fourteen (CTR) independent experiments (a; mean ± s.e.m.), one experiment representative of three experiments (b, left), three independent experiments with technical triplicates (b, right; mean ± s.e.m. of n = 9 replicates), one experiment representative of three experiments (c), one experiment representative of four independent experiments (d, left), or four independent experiments (Foxp3) with technical triplicates from four subjects (n = 12) or three independent experiments (STAT5) with technical triplicates from three subjects (n = 9) (d, right), one experiment representative of three (e, left) or three independent experiments with nine technical replicates from three sets of twins (e, right; n = 27). A r t i c l e s of PBMCs from healthy human donors, whereas CD4 + cells expressing total Foxp3 represented 10.20% ± 3.97% of these cells (Supplementary Fig. 6a ). Flow cytometry revealed that CD4 + Foxp3-E2 + cells had higher expression of T reg cell-associated markers (CD25, CTLA-4, GITR, CD39 and CD71) than did CD4 + cells that expressed total Foxp3 (Supplementary Fig. 6b,c) , and they were more proliferative and metabolically active than CD4 + cells that expressed total Foxp3, as indicated by their larger amounts of Ki67 and phosphorylated S6 (Supplementary Fig. 6d ). These findings suggested that among all the peripheral human CD4 + Foxp3 + T cells, those containing the region encoded by exon 2 represented the fraction with the strongest suppressive properties, in agreement with the results we obtained for iT reg cells.
Defective glycolysis and function of iT reg cells in autoimmunity
We next analyzed the relevance of the findings to human autoimmunity, in patients with RRMS who had not undergone treatment and in patients with T1D. Despite the evidence that the proliferation of T conv cells obtained from subjects with RRMS and stimulated in vitro with mAb to CD3 plus mAb to CD28 was similar to that of their counterparts from healthy control subjects ( Supplementary  Fig. 7a) , glycolysis was impaired in T conv cells from subjects with RRMS, as indicated by their diminished basal and maximal glycolysis and glycolytic capacity ( Fig. 7a and Supplementary Fig. 7b) . iT reg cells generated from T conv cells of subjects with RRMS demonstrated diminished in vitro suppressive ability relative to that of those generated from healthy age-and sex-matched control subjects (Fig. 7b) . Moreover, iT reg cells from subjects with RRMS had reduced expression of Foxp3-E2, CTLA-4, PD-1 and CD71 and less phosphorylation of S6, and slightly increased expression of GITR, compared with that of iT reg cells from healthy control subjects (Fig. 7c) . There was also impaired induction in expression of the 47-kDa and 44-kDa forms of Foxp3 in T conv cells from subjects with RRMS at 24 and 36 h after stimulation with a minimal dose of mAb to CD3 plus mAb to CD28, together with impairment of the IL-2-IL-2R-STAT5 signaling pathway at 24 h (Fig. 7d) . We also confirmed the specific decrease in Foxp3-E2 expression in T conv cells from subjects with RRMS, by immunoblot analysis with mAb to Foxp3-E2 ( Supplementary  Fig. 7c ). Of note, we also confirmed those findings in studies of monozygotic twins discordant for RRMS (one twin affected and one twin healthy) who had also not undergone treatment (Fig. 7e) , as measured by the induction of Foxp3-E2 in T conv cells stimulated in vitro with mAb to CD3 plus mAb to CD28 (Supplementary Fig. 1) . Notably, we observed a profound delay in the induction of both the 47-kDa form of Foxp3 and the 44-kDa form of Foxp3 in T conv cells from the twin with RRMS at 24 h, relative to the induction in such cells from the healthy twin (Fig. 7e) . At 36 h, the level of the 44-kDa form of Foxp3 was not significantly lower than its abundance in T conv cells from the healthy twin, whereas the 47-kDa form of Foxp3 was still profoundly lower in abundance (Fig. 7e) .
To explore whether altered induction of Foxp3-E2 was a specific feature of RRMS or was instead a common phenomenon in autoimmunity, we also evaluated the induction of Foxp3, T reg cell markers and IL-2-IL-2R-STAT5 signaling in T conv cells obtained from subjects with early-onset T1D and stimulated in vitro with mAb to CD3 plus mAb to CD28 (Supplementary Fig. 1 ). We found that iT reg cells from subjects with T1D had lower expression of Foxp3-E2, CTLA-4, PD-1 and GITR, without differences in the phosphorylation of S6 or expression of CD71, relative to that of iT reg cells from age-matched healthy control subjects, as assessed by flow cytometry (Fig. 8a) . At both 24 h npg and 36 h, there was marked impairment in induction of the 47-and 44-kDa forms of Foxp3 in subjects with T1D relative to their induction in healthy control subjects (Fig. 8b) . These phenomena correlated with a significant reduction in the phosphorylation of STAT5 observed at 24 h in T conv cells from subjects with T1D, relative to its phosphorylation in such cells from healthy control subjects (Fig. 8b) . We confirmed, by immunoblot analysis with mAb to Foxp3-E2, the specific decrease in Foxp3-E2 (Supplementary Fig. 7d ). Of note, we confirmed again the impairment in the induction of Foxp3-E2 in monozygotic twins discordant for T1D. At 24 h, the level of the 47-and 44-kDa forms of Foxp3 in T conv cells from the affected twin was similar to that in cells from the healthy twin, while at 36 h the 47-kDa form was much less abundant in cells from the affected twin than in cells from the healthy twin (Fig. 8c) , which confirmed our findings for Foxp3-E2 expression in RRMS, another autoimmune disease. Overall, our data suggested that T conv cells from healthy subjects exhibited normal glycolysis during in vitro stimulation with mAb to CD3 plus mAb to CD28, which led to the generation of functional iT reg cells that expressed appropriate amounts of Foxp3-E2 (Supplementary Fig. 8 ). In subjects with autoimmunity, impaired glycolysis during T conv cell stimulation led to reduced expression of Foxp3-E2 that would account for the diminished regulatory ability of iT reg cells (Supplementary Fig. 8 ).
DISCUSSION
Here we found that glycolysis was indispensable for the generation of human iT reg cells from T conv cells through localization of the glycolytic enzyme enolase-1 to the nucleus, which directly affected the induction of specific splicing variants of Foxp3-E2 after enolase-1 bound to the Foxp3 promoter and CNS2. We confirmed our findings in two different human autoimmune diseases, RRMS and T1D. This emphasizes the link between metabolism and immunotolerance in the development of autoimmunity.
Human iT reg cells can be generated anew from non-regulatory T conv cells, following suboptimal stimulation of the TCR and without the requirement for exogenous regulatory-type cytokines or drugs; this provides evidence that TCR signal strength is a critical determinant of the induction of Foxp3, the generation of T reg cells and the engagement of specific metabolic programs during the activation of T conv cells 11, [17] [18] [19] 31 . In our experimental system, weak (0.1 bead per cell) and short (36-hour) activation of T conv cells via the TCR gave rise to iT reg cells that were the highly proliferative and metabolically active fraction of activated T cells (whose generation closely relies on glycolysis). 2DG (a glycolytic inhibitor) affected the induction of Foxp3, reduced the expression of T reg cell markers and impaired the suppressive function of iT reg cells. The inhibition of FAO via Etx increased Foxp3 expression and induced iT reg cells with stronger regulatory properties. These results are in agreement with published reports showing that the engagement of distinct metabolic pathways controls the function and differentiation of T cells [17] [18] [19] .
Glycolysis fuels the energetic and biosynthetic demands of CD4 + T cell growth and proliferation and represents the metabolic program necessary for appropriate cell activation 17, 21, 32 . Compelling experimental evidence suggests that during maximal activation of CD4 + T cells, autocrine secretion of IL-2 induces Foxp3 in a small fraction of cells, which leads to conversion into Foxp3 + T reg cells, whose stability over time has been questioned 33 . We observed here that weak stimulation of the TCR generated Foxp3 + iT reg cells that were stable over time. Therefore, we speculate that the activation of T conv cells induces a self-limiting mechanism of activation through the generation of iT reg cells and thereby induces the maintenance of tolerance. This could help to explain the apparent paradox of the association of T cell immunodeficiency with autoimmunity 34, 35 ; i.e., a reduced activation rate of T cells (immunodeficiency) might diminish the generation of iT reg cells necessary to replenish the peripheral pool of T reg cells (autoimmunity).
Our study has also demonstrated a crucial role for the glycolytic enzyme enolase-1 and its isoform (i.e., MBP-1) in modulating the expression of specific splicing forms of Foxp3 that were indispensable for the suppressive function of iT reg cells. So far, about twelve different Foxp3 transcripts have been reported, as well as four to eight different splicing forms of the protein (ranging from 18 kDa to 49 kDa), but their functions are not completely understood [22] [23] [24] 26 . We found that treatment with 2DG was able to diminish the abundance of the Foxp3-E2 splice forms, which we found were necessary for the regulatory function of iT reg cells (as exemplified by the reduced suppressive ability of both iT reg -2DG cells and cells generated with siRNA-E2, in which Foxp3-E2 was silenced). The splice form that accounted for the suppressive activity of iT reg cells was the 47-kDa form, which contains the region encoded by exon 2. The role of that region has been assessed at a molecular level in various experimental systems [36] [37] [38] . Foxp3 can block the activity of RORγt, a transcription factor associated with the T H 17 subset of helper T cells, through direct interaction involving the region encoded by exon 2 (ref. 36) . Foxp3 interacts also with the transcription factor RORα, and mutations of sequence in exon 2 encoding the 'LxxLL' motif (where 'x' indicates any amino acid) hamper the interaction and repression by Foxp3 (refs. 37, 38) . In addition, CD4 + CD25 + T cells containing spliced forms of Foxp3 lacking exon 2 are less hypo-responsive and produce more IL-2 than are CD4 + CD25 + T cells containing the Foxp3-E2 splicing form 24 .
The recruitment of different factors to Foxp3 regulatory elements can influence gene expression or alternative splicing through a combination of physical mechanisms ranging from direct interaction to transient chromatin modification. Among those factors, MBP-1, which is derived from alternative translation of ENo1 transcripts, has been reported to bind DNA and to suppress gene expression [27] [28] [29] [30] . We found that under conditions of inhibition of glycolysis (treatment with 2DG), there was an increase in enolase-1 on both the Foxp3 promoter and Foxp3 CNS2, and this was associated with reduced expression of total Foxp3 and the Foxp3-E2 splicing variant. In addition, when glycolysis was inhibited (in iT reg -2DG cells) during RNA-mediated interference of ENo1, the observed recovery of total Foxp3 and the Foxp3-E2 isoform depended on the non-glycolytic activity of enolase-1. In contrast, silencing of ENo1 in the absence of treatment with 2DG (in iT reg -CTR cells) lead to a reduction in Foxp3 expression that could be ascribed to impairment of the glycolytic activity of enolase-1. Our data have identified a previously unknown molecular mechanism that links a specific glycolytic enzyme to the regulation of a 'master gene' (Foxp3) whose product is necessary for the induction and function of T reg cells. In resting T conv cells, with low glycolytic demands, enolase-1 was specifically recruited to Foxp3 regulatory regions, and this correlated with no Foxp3 expression. Activation of the TCR led to an increase in glucose uptake and glycolysis, which supported the energetic needs of T conv cells and drove appropriate Foxp3 expression; impairment of the glycolytic pathway (with 2DG) during the activation of T conv cells hampered the induction of Foxp3-E2 after accumulation of the enolase-1 isoforms in the nucleus on Foxp3 regulatory regions. This indicated that glycolysis was required for the generation of iT reg cells following the activation of T conv cells. We also found that iT reg -2DG cells had an impairment in the IL-2-IL-2R-STAT5 signaling pathway (which has a pivotal role in the induction of Foxp3 and the generation and homeostasis of T reg cells) 25, 39 , whereas iT reg -Etx cells exhibited more npg activation of this pathway. In T conv cells, a major consequence of IL-2 signaling is the phosphorylation of STAT5, which binds to the Foxp3 promoter; this leads to Foxp3 expression and the acquisition of suppressive ability by the cells 40, 41 . This is a key event in the generation of T reg cells, as shown by the fact that STAT5-or IL-2Rγ-deficient mice have considerably fewer Foxp3 + T reg cells than their wild-type counterparts have 42 . We applied those findings to two human autoimmune diseases, including studies of disease-discordant monozygotic twins, in which a reduced suppressive function of iT reg cells was associated specifically with impaired expression of Foxp3-E2, secondary to a glycolytic defect during the activation of T conv cells. In summary, our data suggest that distinct metabolic pathways contribute to the generation of 'waves' of T reg cells during T cell activation to replenish the peripheral T reg cell pool and protect from loss of immunotolerance 34, 35 . Targeted manipulation of metabolic disturbances could be instrumental in modulating immunotolerance in autoimmunity.
METHODS
Methods and any associated references are available in the online version of the paper. 
